GLYCOPYRROLATE
- Product NDC
- 51662-1425
- 11-digit product format
- 516621425
- Labeler code
- 51662
- Product ID
- 51662-1425_2b382c02-1322-a447-e063-6394a90ac5c1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GLYCOPYRROLATE
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA208973
- Marketing category
- ANDA
- Marketing start
- 2019-12-21
- Substance
- GLYCOPYRROLATE
- Active strength
- .2 mg/mL
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V92SO9WP2I | GLYCOPYRROLATE | 51186-83-5 | GLYCOPYRROLATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51662-1425-1 | 51662142501 | 1 mL in 1 VIAL (51662-1425-1) | 1 ml | 2019-12-21 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| GLYCOPYRROLATE INJECTION | HF Acquisition Co LLC, DBA HealthFirst | 2025-01-08 | HUMAN PRESCRIPTION DRUG LABEL | 3 |